Phathom Pharmaceuticals Stock (NASDAQ: PHAT) stock price, news, charts, stock research, profile.
|Vol / Avg.1.027M / 491.903K||Mkt Cap494.089M|
|Day Range7.350 - 8.690||52 Wk Range5.840 - 17.019|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|2023-11-03||Goldman Sachs||Paul Choi||Maintains||NeutralNeutral||Raises||9.00||10.00|
|2023-08-11||HC Wainwright & Co.||Matthew Caufield||Reiterates||BuyBuy||Maintains||-||28.00|
|Ticker||Company||Chg %||Mkt Cap|
|THRD||Third Harmonic Bio||2.81%||383.4M|
You can purchase shares of Phathom Pharmaceuticals (NASDAQ: PHAT) through any online brokerage.
The latest price target for Phathom Pharmaceuticals (NASDAQ: PHAT) was reported by Needham on Friday, November 10, 2023. The analyst firm set a price target for 23.00 expecting PHAT to rise to within 12 months (a possible 166.51% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Phathom Pharmaceuticals (NASDAQ: PHAT) is $8.63 last updated December 4, 2023 at 10:31 PM UTC.
There is no dividend information for Phathom Pharmaceuticals.
Phathom Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 27, 2024.
There is no upcoming split for Phathom Pharmaceuticals.
Phathom Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.